ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Zylox-Tonbridge Medical Technology Co., Ltd.

Equities

2190

CNE100004JD2

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 08:08:20 13/03/2026 GMT			5-day change	1st Jan Change
21.36 ^HKD	-2.11%		+3.39%	-7.53%

01-30	Zylox-Tonbridge Medical Forecasts 139% Profit Jump in 2025	MT
01-29	Zylox-Tonbridge Medical Technology sees revenue more than RMB1.05 billion for year	RE

Tranche Update on Zylox-Tonbridge Medical Technology Co., Ltd.'s Equity Buyback Plan announced on August 23, 2024.

Published on 08/19/2025 at 12:56 pm BST

S&P Capital IQ

ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

-2.11%

From January 1, 2025 to May 30, 2025, the company has repurchased 2,462,000 shares, representing 0.77% for HKD 39.41 million. With this, the company has completed the repurchase of 6,495,000 shares, representing 2.01% for HKD 85.43 million under the buyback announced on August 23, 2024.

Latest news about Zylox-Tonbridge Medical Technology Co., Ltd.

01-30	Zylox-Tonbridge Medical Forecasts 139% Profit Jump in 2025	MT
01-29	Zylox-Tonbridge Medical Technology sees revenue more than RMB1.05 billion for year	RE
01-29	Zylox-Tonbridge Medical Technology Co., Ltd. Provides Group Earnings Guidance for the Year Ended December 31, 2025	CI
01-16	Zylox-Tonbridge to Acquire Stake in German Medical Technology Firm	MT
01-16	Zylox-Tonbridge Medical Technology announces acquisition of 49% stake in Optimed Holding GmbH	RE
01-14	Zylox-Tonbridge Medical Technology Co., Ltd. entered into the Sale and Purchase Agreement to acquire 49% stake in Optimed Holding GmbH from E Med Solutions GmbH for ?18.4 million.	CI
01-12	Zylox-Tonbridge Medical Technology Co., Ltd. Showcases Broad Portfolio of Commercialized and Late-Stage Pipeline Products	CI
27/10/25	Zylox-Tonbridge Medical Technology Grants Share Awards; Shares Up 4%	MT
08/10/25	Zylox-Tonbridge Medical Shareholders to Vote on Share Incentive Scheme on Oct. 24	MT
20/08/25	Zylox-Tonbridge's H1 Profit Rises on Higher Revenue	MT
19/08/25	Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
19/08/25	Tranche Update on Zylox-Tonbridge Medical Technology Co., Ltd.'s Equity Buyback Plan announced on August 23, 2024.	CI
19/08/25	Tranche Update on Zylox-Tonbridge Medical Technology Co., Ltd.'s Equity Buyback Plan announced on May 30, 2025.	CI
23/07/25	Zylox-Tonbridge Medical Technology Co., Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2025	CI
23/07/25	Zylox-Tonbridge Forecasts 67% H1 Profit Surge; Shares Rise 6%	MT

Chart Zylox-Tonbridge Medical Technology Co., Ltd.

Duration

Period

Chart Zylox-Tonbridge Medical Technology Co., Ltd.

2190: Dynamic Chart

Company Profile

Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.

Employees

875

Sector

Medical Equipment, Supplies & Distribution

Calendar

03-17 - Earnings release - Annual 2025

More about the company